-
Global Biotechnology & Pharmaceutical Markets1 week agoSanofi breaks ground on insulin plant after securing German government support
The European Commission approved Germany’s financial support after assessing the risks of Sanofi stopping insulin API production at the Frankfurt campus.
-
Global Biotechnology & Pharmaceutical Markets1 week agoUK Biobank partners with industry on ‘most detailed’ immune map
The UK Biobank has teamed up with industry partners to create "the world’s most detailed, large-scale picture of the human immune system."
-
Global Biotechnology & Pharmaceutical Markets1 week agoData reveal is promising for GSK’s lung cancer drug ris-rez
The first data from GSK's international trial of B7-H3-targeted ADC ris-rez in small cell lung cancer back up earlier results from a Chinese study.
-
Global Biotechnology & Pharmaceutical Markets1 week agoMerck/Moderna, Summit/Akeso and ADCs to headline ESMO 2026
At the European Society of Medical Oncology meeting in Madrid this weekend, analysts will be watching for detailed data on Merck and Moderna’s personalized cancer vaccine,...
-
Global Biotechnology & Pharmaceutical Markets1 week agoJapan’s National Center Biobank Network Tops 250,000 Participants and 800,000 Biospecimens
A new review details how Japan's National Center Biobank Network has grown past 250,000 participants and 800,000 biospecimens, fueling discoveries from kidney cancer mutational signatures to...
-
Global Biotechnology & Pharmaceutical Markets2 weeks agoDesign and optimization of a multi-band spiral antenna for frequency-dependent hyperthermia heating in head and neck cancer treatment
Engineers in India have built a single spiral antenna that can heat tumors at three different depths inside the head and neck simply by switching between...
-
Global Biotechnology & Pharmaceutical Markets2 weeks agoSTAT+: RevMed’s pancreatic cancer drug nears European approval
Following a green light from the FDA, European regulators have now recommended the approval of Revolution Medicines' Rasonque for pancreatic cancer.
-
Global Biotechnology & Pharmaceutical Markets2 weeks agoOrbiMed raises two new life sciences funds worth $3B with one aiming for Asia
The sixth cycle of OrbiMed’s Asia Partners fund included one with more than $1 billion earmarked for life science companies based on the Eastern continent.
-
Global Biotechnology & Pharmaceutical Markets2 weeks agoRoche turns to China’s Rona for ALK7-siRNA for selective fat loss
BIOCENTURY | DEALSROCHE TURNS TO CHINA’S RONA FOR ALK7-SIRNA FOR SELECTIVE FAT LOSSChina biotechs fuel a growing RNAi pipeline silencing ALK7 in adipocytes
-
Global Biotechnology & Pharmaceutical Markets2 weeks agoChina’s RNAi pipeline drives dealmaking with the West
BIOCENTURY | DATA BYTECHINA’S RNAI PIPELINE DRIVES DEALMAKING WITH THE WESTCardiometabolic programs lead the dealmaking as China’s developers push delivery beyond the liver
Genmab’s cancer bispecific delivers early survival win in ‘exceedingly positive’ Phase 3 readout
Genmab’s cancer bispecific delivers early OS win in ‘exceedingly positive’ Phase 3 readout
STAT+: HHS moves to allow compounding of some unapproved peptides
Novartis buys Synnovation’s PI3Kα inhibitors for $3 billion
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
